Search research articles
Contact Us
Filters
Showing results (51-60 of 155) with videos related to
Page
of 16
Sort By:
Bone Marrow Transplantation
|
December 15, 2018
A survey on incidence and management of adenovirus infection after allogeneic HSCT
Simone Cesaro, Massimo Berger, Gloria Tridello, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
May 23, 2014
Donor cytomegalovirus status influences the outcome of allogeneic stem cell transplant: a study by the European group for blood and marrow transplantation
Per Ljungman, Ronald Brand, Jennifer Hoek, et al.
Bone Marrow Transplantation
|
October 23, 2023
Prevalence, management, and new treatment modalities of EBV-DNA-emia and EBV-PTLD after allo-HCT: survey of Infectious Diseases Working Party EBMT
Jan Styczynski, Gloria Tridello, Lotus Wendel, et al.
Anticancer Research
|
May 23, 2002
In vitro activity of glufosfamide in childhood acute leukemia
Jan Styczynski, Mariusz Wysocki, Andrzej Kurylak, et al.
Anticancer Research
|
January 30, 2008
Activity of bortezomib in adult de novo and relapsed acute myeloid leukemia
Lidia Gil, Jan Styczynski, Dominik Dytfeld, et al.
Anticancer Research
|
December 11, 2012
Comparison of prognostic value of in vitro drug resistance and bone marrow residual disease on day 15 of therapy in childhood acute lymphoblastic leukemia
Jan Styczynski, Magdalena Piatkowska, Anna Jaworska-Posadzy, et al.
The Lancet. Oncology
|
July 4, 2014
Fourth European Conference on Infections in Leukaemia (ECIL-4): guidelines for diagnosis, prevention, and treatment of invasive fungal diseases in paediatric patients with cancer or allogeneic haemopoietic stem-cell transplantation
Andreas H Groll, Elio Castagnola, Simone Cesaro, et al.
Infection and Drug Resistance
|
January 8, 2020
Epidemiology, Outcome and Risk Factors Analysis of Viral Infections in Children and Adolescents Undergoing Hematopoietic Cell Transplantation: Antiviral Drugs Do Not Prevent Epstein-Barr Virus Reactivation
Krzysztof Czyzewski, Magdalena Dziedzic, Malgorzata Salamonowicz, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society
|
December 17, 2021
Current attitude to deferral of cellular therapy or nontransplant chemotherapy due to SARS-CoV-2 asymptomatic infection: Survey of Infectious Diseases Working Party EBMT
Jan Styczynski, Simone Cesaro, Marie von Lilienfeld-Toal, et al.
The Lancet. Infectious Diseases
|
April 6, 2025
Recommendations from the 10th European Conference on Infections in Leukaemia for the management of cytomegalovirus in patients after allogeneic haematopoietic cell transplantation and other T-cell-engaging therapies
Per Ljungman, Sophie Alain, Roy F Chemaly, et al.
Page
of 16
Search research articles
Search
Showing results (51-60 of 155) with videos related to
Sort By:
Page
of 16
Bone Marrow Transplantation
|
December 15, 2018
A survey on incidence and management of adenovirus infection after allogeneic HSCT
Simone Cesaro, Massimo Berger, Gloria Tridello, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
May 23, 2014
Donor cytomegalovirus status influences the outcome of allogeneic stem cell transplant: a study by the European group for blood and marrow transplantation
Per Ljungman, Ronald Brand, Jennifer Hoek, et al.
Bone Marrow Transplantation
|
October 23, 2023
Prevalence, management, and new treatment modalities of EBV-DNA-emia and EBV-PTLD after allo-HCT: survey of Infectious Diseases Working Party EBMT
Jan Styczynski, Gloria Tridello, Lotus Wendel, et al.
Anticancer Research
|
May 23, 2002
In vitro activity of glufosfamide in childhood acute leukemia
Jan Styczynski, Mariusz Wysocki, Andrzej Kurylak, et al.
Anticancer Research
|
January 30, 2008
Activity of bortezomib in adult de novo and relapsed acute myeloid leukemia
Lidia Gil, Jan Styczynski, Dominik Dytfeld, et al.
Anticancer Research
|
December 11, 2012
Comparison of prognostic value of in vitro drug resistance and bone marrow residual disease on day 15 of therapy in childhood acute lymphoblastic leukemia
Jan Styczynski, Magdalena Piatkowska, Anna Jaworska-Posadzy, et al.
The Lancet. Oncology
|
July 4, 2014
Fourth European Conference on Infections in Leukaemia (ECIL-4): guidelines for diagnosis, prevention, and treatment of invasive fungal diseases in paediatric patients with cancer or allogeneic haemopoietic stem-cell transplantation
Andreas H Groll, Elio Castagnola, Simone Cesaro, et al.
Infection and Drug Resistance
|
January 8, 2020
Epidemiology, Outcome and Risk Factors Analysis of Viral Infections in Children and Adolescents Undergoing Hematopoietic Cell Transplantation: Antiviral Drugs Do Not Prevent Epstein-Barr Virus Reactivation
Krzysztof Czyzewski, Magdalena Dziedzic, Malgorzata Salamonowicz, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society
|
December 17, 2021
Current attitude to deferral of cellular therapy or nontransplant chemotherapy due to SARS-CoV-2 asymptomatic infection: Survey of Infectious Diseases Working Party EBMT
Jan Styczynski, Simone Cesaro, Marie von Lilienfeld-Toal, et al.
The Lancet. Infectious Diseases
|
April 6, 2025
Recommendations from the 10th European Conference on Infections in Leukaemia for the management of cytomegalovirus in patients after allogeneic haematopoietic cell transplantation and other T-cell-engaging therapies
Per Ljungman, Sophie Alain, Roy F Chemaly, et al.
Page
of 16